James Brorson to Ischemic Attack, Transient
This is a "connection" page, showing publications James Brorson has written about Ischemic Attack, Transient.
Connection Strength
2.560
-
Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population. J Stroke Cerebrovasc Dis. 2025 Jul; 34(7):108349.
Score: 0.815
-
Vulnerable and Stabilized States After Cerebral Ischemic Events: Implications of Kinetic Modeling in the SOCRATES, POINT, and THALES Trials. Neurology. 2023 11 27; 101(22):e2205-e2214.
Score: 0.737
-
Predictors of very early stroke recurrence in the POINT trial population. BMC Neurol. 2022 May 14; 22(1):177.
Score: 0.662
-
Ipsilateral Nonstenotic Carotid Disease in Minor Ischemic Stroke: an Exploratory Analysis of The POINT Randomized Clinical Trial. J Stroke Cerebrovasc Dis. 2020 Nov; 29(11):105115.
Score: 0.147
-
BE-FAST: A Sensitive Screening Tool to Identify In-Hospital Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2020 Jul; 29(7):104821.
Score: 0.143
-
Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial. Catheter Cardiovasc Interv. 2003 Dec; 60(4):524-8.
Score: 0.046
-
Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediate-term risk of recurrent neurological events. Catheter Cardiovasc Interv. 2002 Feb; 55(2):189-94.
Score: 0.010